Tulane Outbreak

Readers: A common theme I have noticed in the past few days has been reports of blood clots, strokes, gastro issues with positive COVID-19 patients. Please leave a comment on this post if you have any further information, or have seen similar cases in your part of the world. The Tulane Outbreak Daily email reaches about 3,000 researchers, doctors, and other health care professionals around the world. This is a great place to start a discussion or crowdsource a question.

Featured Headlines

Why Is COVID-19 Coronavirus Causing Strokes In Young And Middle-Aged People? – Forbes

We are also learning more and more about the devastating effects of this virus as it attacks other organs including the kidney, heart and the brain. However, the virus’s ultimate target that may inflict the most damage—via either a direct effect of the virus, hypoxia, (low oxygen), secondary inflammation or disseminated intravascular coagulation (DIC)—are blood vessels, leading to formation of blood clots, or excessive bleeding (DIC) in some cases, a consequence of consumption of clotting factors.

Bacterial superinfection and mortality in viral pneumonia such as influenza and COVID-19 – FLARE

The FLARE team investigates secondary bacterial infections in viral respiratory infections prior to COVID-19. Available data on secondary infections in COVID-19 are limited but do indicate that nosocomial infections are associated with increased COVID-19 severity and death. Risk factors for secondary bacterial and fungal infections include invasive devices (central venous catheters), diabetes, combination antibiotic therapy, and glucocorticoid treatment. Given long ICU stays associated with COVID-19, it is likely that rates of secondary bacterial infection will reflect, in part, nosocomial infections that are common in critical illness.

India coronavirus: The ‘mystery’ of low Covid-19 death rates

Most affected countries have inadvertently under-reported deaths. Studying mortality data in 12 countries, The New York Times found that in March at least 40,000 more people died during the coronavirus pandemic than the official death counts. These include deaths from the contagion as well as those from other likely causes. [Related Study]

Could genetics explain the confusing array of SARS-CoV-2 symptoms? – ARS Technica

A dry cough. Loss of smell. Diarrhea. Fever. All of these have been considered possible symptoms associated with SARS-CoV-2 infection, along with the complete absence of symptoms at all. In the absence of a sufficient testing capacity, many areas in the United States are being compelled to allocate their limited tests to only those who seem to have COVID-19 symptoms. But, given the difficulty of determining which symptoms actually indicate a likely infection, those are difficult decisions to make. [Related pre-pub study]

What policy makers need to know about COVID-19 protective immunity – The Lancet

About a third of the world is under lockdown as a public health measure to curb the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). Policy makers are increasingly pressed to articulate their rationales and strategies for moving out of lockdown; the process of re-emergence is already cautiously starting in Austria, Switzerland, Denmark, Wuhan, and some US states. As the counterpoise between further disease spread and socioeconomic costs is debated, it is essential that policy makers in all affected countries have the best possible data and understanding to inform any course of action.

What if immunity to covid-19 doesn’t last? – MIT Technology Review

Starting in the fall of 2016 and continuing into 2018, researchers at Columbia University in Manhattan began collecting nasal swabs from 191 children, teachers, and emergency workers, asking them to record when they sneezed or had sore throats. The point was to create a map of common respiratory viruses and their symptoms, and how long people who recovered stayed immune to each one. [Related pre-pub study]

Many asymptomatic COVID-19 cases undetected – CIDRAP

More than half of residents of a Seattle-area nursing home had no symptoms when they tested positive for COVID-19 and had probably already spread the disease. [Related NEJM Study]

Heightened levels of SARS-CoV-2 RNA found in the air in some patient areas – Medical Express

Analyzing the samples for evidence of SARS-CoV-2 RNA, the researchers found dramatically different concentrations. As expected, they found much higher concentrations of the virus in the air where there were high concentrations of infected patients. They noted that concentrations were generally low in areas that were well ventilated. However, other areas, such as unventilated public toilets used by patients, were found to have much higher concentrations. [Related Study]

Myocardial Injury Common in COVID-19 – Med Page Today

Troponin elevations largely mild, but still linked to death in NYC hospitals [Related pre-print study]

Effect of Latitude on COVID-19 – CEBM

To look at this further and try and explain why some countries are disproportionately affected (see Six Countries: Three-Quarters of the COVID-19 Deaths) we analysed the effect of latitude on global deaths and cases per million in the Northern Hemisphere and globally. [Related Research]

Virus Likely to Keep Coming Back Each Year, Say Top Chinese Scientists – Bloomberg

It’s unlikely the new virus will disappear the way its close cousin SARS did 17 years ago, as it infects some people without causing obvious symptoms like fever. This group of so-called asymptomatic carriers makes it hard to fully contain transmission as they can spread the virus undetected. [Related Study]

U.K. Issues Warning Over Possible Coronavirus-Linked Illness in Kids – Bloomberg

The U.K. Paediatric Intensive Care Society posted an alert on Twitter reporting an increase in the number of children presenting the symptoms over the last three weeks, with some needing intensive care treatment. Abdominal pain, gastrointestinal problems and cardiac inflammation — consistent with toxic shock syndrome and atypical Kawasaki disease — are among the symptoms appearing, according to the NHS alert.

‘Spider-Man’ Immune Response May Promote Severe COVID-19 – Scientific American

Clinical trials have begun to test drugs that counter toxic molecular webs linked to lung distress. The menagerie of immune cells and proteins that defend the human body have received mounting scrutiny in struggles to ward off COVID-19. A lot of the debate has centered around whether, after recovery, a person carrying antibodies can safely return to the workplace. But attention has also turned to runaway immune reactions provoked by the infection that can lead to respiratory failure. [Related Study]

Surveillance

Official Reporting for April 28, 2020